London & Capital Asset Management Ltd Cuts Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

London & Capital Asset Management Ltd lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 57,612 shares of the medical equipment provider’s stock after selling 1,418 shares during the period. Intuitive Surgical comprises 1.6% of London & Capital Asset Management Ltd’s investment portfolio, making the stock its 26th biggest position. London & Capital Asset Management Ltd’s holdings in Intuitive Surgical were worth $19,436,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. RB Capital Management LLC boosted its position in Intuitive Surgical by 4.4% during the first quarter. RB Capital Management LLC now owns 1,735 shares of the medical equipment provider’s stock worth $523,000 after acquiring an additional 73 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its position in Intuitive Surgical by 0.6% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 946,709 shares of the medical equipment provider’s stock worth $285,603,000 after acquiring an additional 5,233 shares during the last quarter. Baird Financial Group Inc. boosted its position in Intuitive Surgical by 2.3% during the first quarter. Baird Financial Group Inc. now owns 21,089 shares of the medical equipment provider’s stock worth $6,362,000 after acquiring an additional 481 shares during the last quarter. Brown Brothers Harriman & Co. boosted its position in Intuitive Surgical by 576.7% during the first quarter. Brown Brothers Harriman & Co. now owns 406 shares of the medical equipment provider’s stock worth $122,000 after acquiring an additional 346 shares during the last quarter. Finally, Covestor Ltd boosted its position in Intuitive Surgical by 50.4% during the first quarter. Covestor Ltd now owns 418 shares of the medical equipment provider’s stock worth $126,000 after acquiring an additional 140 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several recent analyst reports. Citigroup boosted their target price on shares of Intuitive Surgical from $428.00 to $462.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Raymond James boosted their target price on shares of Intuitive Surgical from $372.00 to $435.00 and gave the company an “outperform” rating in a report on Thursday, January 25th. StockNews.com lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. Truist Financial upped their price objective on shares of Intuitive Surgical from $390.00 to $435.00 and gave the stock a “buy” rating in a report on Wednesday, January 24th. Finally, Royal Bank of Canada upped their price objective on shares of Intuitive Surgical from $400.00 to $432.00 and gave the stock an “outperform” rating in a report on Wednesday, January 24th. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $375.70.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG traded down $0.15 during trading hours on Monday, reaching $384.65. The stock had a trading volume of 341,826 shares, compared to its average volume of 1,618,073. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $403.76. The firm’s 50 day moving average is $388.26 and its 200-day moving average is $340.99. The stock has a market capitalization of $136.34 billion, a price-to-earnings ratio of 76.94, a P/E/G ratio of 5.97 and a beta of 1.36.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, January 23rd. The medical equipment provider reported $1.60 EPS for the quarter, beating analysts’ consensus estimates of $1.48 by $0.12. Intuitive Surgical had a net margin of 25.24% and a return on equity of 13.11%. The company had revenue of $1.93 billion for the quarter, compared to the consensus estimate of $1.89 billion. During the same period in the prior year, the firm posted $0.91 EPS. The company’s quarterly revenue was up 16.6% compared to the same quarter last year. Analysts forecast that Intuitive Surgical, Inc. will post 4.93 EPS for the current year.

Insider Activity

In other news, EVP Myriam Curet sold 4,318 shares of the company’s stock in a transaction on Friday, January 26th. The shares were sold at an average price of $370.15, for a total value of $1,598,307.70. Following the completion of the transaction, the executive vice president now owns 189 shares in the company, valued at approximately $69,958.35. The sale was disclosed in a document filed with the SEC, which is available at this link. In related news, EVP Myriam Curet sold 4,318 shares of the stock in a transaction on Friday, January 26th. The shares were sold at an average price of $370.15, for a total transaction of $1,598,307.70. Following the completion of the sale, the executive vice president now owns 189 shares in the company, valued at approximately $69,958.35. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Alan J. Levy sold 2,000 shares of the stock in a transaction on Friday, January 26th. The stock was sold at an average price of $370.20, for a total transaction of $740,400.00. Following the sale, the director now owns 25,319 shares of the company’s stock, valued at approximately $9,373,093.80. The disclosure for this sale can be found here. In the last quarter, insiders sold 248,418 shares of company stock worth $95,927,097. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.